Valuation: GENFIT

Market Cap 527M 603M 484M 451M 855M 57.4B 870M 5.82B 2.26B 28.15B 2.26B 2.21B 97.01B P/E 2025
-3.06x
P/E 2026 * 55.6x
Enterprise Value 472M 540M 434M 404M 766M 51.44B 779M 5.22B 2.02B 25.23B 2.03B 1.98B 86.93B EV / Sales 2025
2.34x
EV / Sales 2026 * 5.04x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day+18.71%
1 week+23.62%
Current month+18.49%
1 month+46.90%
3 months+68.59%
6 months+142.47%
Current year+138.56%
1 week 10.1
Extreme 10.1
12.72
1 month 8.15
Extreme 8.15
12.72
Current year 5.05
Extreme 5.05
12.72
1 year 3.05
Extreme 3.048
12.72
3 years 2.62
Extreme 2.62
12.72
5 years 2.62
Extreme 2.62
12.72
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 15/09/2019
Director of Finance/CFO 52 21/04/2021
Chief Tech/Sci/R&D Officer - 26/11/2025
Director TitleAgeSince
Chairman 70 15/06/2017
Director/Board Member 54 14/09/1999
Director/Board Member 58 15/06/2017
Date Insider Type Main position Quantity % Market Cap.
03-04Fiscal year

Chief Operating Officer

7,083 0.0142%
03-04Sell

Chief Operating Officer

11,250 0.0225%
03-04Fiscal year

Chief Operating Officer

11,250 0.0225%
Change 5-day change 1-year change 3-year change Capi.($)
+18.71%+23.62%+280.61%+249.86% 603M
+0.27%+5.91%+1.69%+6.95% 49.15B
+0.92%+6.21%+408.85%+607.44% 40.23B
+1.89%+11.06%+25.75%-7.89% 34.55B
+2.38%+8.10%+21.83%+66.94% 33.09B
+1.20%+2.02%+9.79%+32.43% 25.19B
+2.51%+4.94% - - 17.05B
+2.58%+7.24%+71.03%+132.17% 15.92B
-0.38%-0.12%+12.88%+18.27% 13.83B
-1.14%+7.52%+14.75%-30.83% 13.26B
Average +2.90%+6.84%+94.13%+119.48% 24.29B
Weighted average by Cap. +1.23%+6.74%+88.85%+131.25%

Financials

2025 2026 *
Net sales 66.82M 76.47M 61.36M 57.22M 108M 7.28B 110M 739M 286M 3.57B 287M 281M 12.3B 95.2M 109M 87.42M 81.52M 155M 10.37B 157M 1.05B 408M 5.09B 409M 400M 17.53B
Net income -8.3M -9.5M -7.62M -7.11M -13.48M -905M -13.71M -91.79M -35.57M -444M -35.68M -34.9M -1.53B 18.31M 20.95M 16.81M 15.68M 29.72M 1.99B 30.22M 202M 78.44M 978M 78.66M 76.95M 3.37B
Net Debt -54.72M -62.62M -50.25M -46.86M -88.83M -5.96B -90.33M -605M -234M -2.92B -235M -230M -10.08B -46.87M -53.64M -43.04M -40.13M -76.09M -5.11B -77.37M -518M -201M -2.5B -201M -197M -8.63B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change Volume
03/07/26 12.56 +18.71% 1,217,338
02/07/26 €10.58 +2.72% 146,371
01/07/26 €10.30 -2.83% 260,825
30/06/26 €10.60 +0.38% 259,509
29/06/26 €10.56 +3.94% 332,097
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.58EUR
Average target price
14.00EUR
Spread / Average Target
+32.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock